Titan Medical (TMDIF) Stock Price, News & Analysis

Company Overview

Titan Medical Inc. was a Canadian medical device company focused on developing robotic-assisted surgical technologies for minimally invasive procedures. Its principal product was the SPORT Surgical System, later referred to as the Enos Surgical System, which was designed to allow surgeons to control robotic instruments and a three-dimensional visualization system through a single surgical access point.

The company’s technology was intended to support procedures in areas such as general surgery and gynecology by providing enhanced visualization, instrument articulation and a compact system architecture. Titan Medical pursued product development, regulatory and clinical activities primarily in North America, although the system was designed for potential use in international surgical markets.

Titan Medical encountered financial and operational challenges and sought creditor protection in Canada in 2023. Substantially all of its assets were subsequently sold to Conavi Medical Inc., and Titan Medical’s business is no longer generally described as an active standalone developer of surgical robotic systems.

Key Stats

• Today's Range: $0.11 to $0.12
• 50-Day Range: $0.10 to $0.16
• 52-Week Range: $0.03 to $1.00
• Volume: 75,906 shs
• Average Volume: 74,785 shs
• Market Capitalization: $12.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/24/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:TMDIF
• CIK: 840551
• Web: www.titanmedicalinc.com
• Phone: (416) 548-7522
• Fax: N/A
• Employees: 50
• Year Founded: 2008

Profitability

• EPS (Trailing Twelve Months): $0.05
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $6.95 million
• Net Margins: N/A
• Pretax Margin: -1,239.33%
• Return on Equity: -82.31%
• Return on Assets: -51.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.73
• Quick Ratio: 3.73

Sales & Book Value

• Annual Sales: $17.63 million
• Price / Sales: 0.71
• Cash Flow: $5.49 per share
• Price / Cash Flow: 0.02
• Book Value: $1.05 per share
• Price / Book: 0.10

Miscellaneous

• Outstanding Shares: 114,040,000
• Free Float: 4,561,000
• Market Cap: $12.52 million
• Optionable: Not Optionable
• Beta: 1.26